Extremity Medical Expands into Trauma Market

Releases OMNI™ Stable Ankle Fracture System

May 24, 2022

PARSIPPANY, N.J.–(BUSINESS WIRE)–Extremity Medical, a global medical device company focused on the development of innovative implants and instruments for upper and lower extremities, today announced the release of the OMNI™ Stable Ankle Fracture (AF) System.

Ankle fractures are increasingly common injuries requiring careful approaches for proper management. It is estimated that in 2021 over 152,000 ankle fractures occurred in the United States that required internal fixation. This rate is projected to continue, most likely due to growth in the number of people involved in athletics and a larger population of older adults who are more prone to ankle and other lower extremity injuries.

“Extremity Medical has focused on developing a state-of-the-art ankle fracture system that offers surgeons an anatomic implant solution for every fracture location,” said Matthew Lyons, Extremity Medical Chief Executive Officer, Founder and Chairman of the Board. “Additionally, our team designed fixation options to enhance construct stability for patients with poor bone quality or segmental bone loss.”

The OMNI Stable AF System offers a wide variety of low-profile anatomic plates that closely match patient anatomy and minimize soft tissue impingement. The proprietary Stability Post technology design allows optimized stability for patients with poor bone quality, and/or segmental bone loss. In addition, the system provides surgeons with an extensive selection of bone reduction instruments to accommodate even the most difficult cases.

The OMNI Stable AF System was designed in conjunction with an accomplished team of surgeons with extensive ankle fracture treatment experience, including: Timothy Charlton, MD; Charles Moon, MD; and Max Michalski, MD, from Los Angeles; David Garras, MD, from Chicago and Brian Straus, MD from Dallas – Fort Worth.

About Extremity Medical, LLC

Extremity Medical, LLC, was founded in 2008, and is a privately held medical device company based in Parsippany, NJ. The company is known for creating innovative implants and instruments for upper and lower extremity orthopedic procedures, including fusion and motion preservation. The company is focused on developing solutions for challenging cases that promote better outcomes, especially in patients with poor bone quality.

Ira Benson
Vice President of Marketing

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button